Assessment of Nevirapine Prophylactic and Therapeutic Dosing Regimens for Neonates.

MLA

Cressey, Tim R., et al. “Assessment of Nevirapine Prophylactic and Therapeutic Dosing Regimens for Neonates.” Journal of Acquired Immune Deficiency Syndromes (1999), vol. 75, no. 5, Aug. 2017, pp. 554–60. EBSCOhost, https://doi.org/10.1097/QAI.0000000000001447.

APA

Cressey, T. R., Punyawudho, B., Le Coeur, S., Jourdain, G., Saenjum, C., Capparelli, E. V., Jittayanun, K., Phanomcheong, S., Luvira, A., Borkird, T., Puangsombat, A., Aarons, L., Sukrakanchana, P.-O., Urien, S., & Lallemant, M. (2017). Assessment of Nevirapine Prophylactic and Therapeutic Dosing Regimens for Neonates. Journal of Acquired Immune Deficiency Syndromes (1999), 75(5), 554–560. https://doi.org/10.1097/QAI.0000000000001447

Chicago

Cressey, Tim R, Baralee Punyawudho, Sophie Le Coeur, Gonzague Jourdain, Chalermpong Saenjum, Edmund V Capparelli, Kanokwan Jittayanun, et al. 2017. “Assessment of Nevirapine Prophylactic and Therapeutic Dosing Regimens for Neonates.” Journal of Acquired Immune Deficiency Syndromes (1999) 75 (5): 554–60. doi:10.1097/QAI.0000000000001447.